Severe macrophage activation syndrome and central nervous system involvement in juvenile dermatomyositis

Scandinavian Journal of Rheumatology

Volumn 43, Issue 2, 2014, Pages 171-173

  Lilleby, V ^a   Haydon, J ^a   Sanner, H ^a   Krossness, B K ^a   Ringstad, G ^a   Flato, B ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; ETOPOSIDE; FERRITIN; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLINICAL FEATURE; HUMAN; JUVENILE DERMATOMYOSITIS; LETTER; MACROPHAGE ACTIVATION SYNDROME; MALE; MENTAL HEALTH; MUSCLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; WHITE MATTER;

ANTIRHEUMATIC AGENTS; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; DERMATOMYOSITIS; EDEMA; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MACROPHAGE ACTIVATION SYNDROME; MALE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84895751926     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2013.863968     Document Type: Letter

References (10)

1. Zedan M, El-Ayouty M, Abdel-Hady H, Shouman B, El-Assmy M, Fouda A. Anasarca: Not a nephrotic syndrome but dermatomyositis. Eur J Pediatr 2008;167:831-4
2. Ramanan AV, Sawhney S, Murray KJ. Central nervous system complications in two cases of juvenile onset dermatomyositis. Rheumatology (Oxford) 2001;40:1293-8
3. Chandrakasan S, Singh S, Ratho RK, Kumar S, Mishra B. Anasarca as the presenting manifestation of parvovirus B19 associated juvenile dermatomyositis. Rheumatol Int 2009;29:565-7
4. Dwivedi N, Michael C, Lew DB, Arnold S, Igarashi M, Bertorini T, et al. A fatal presentation of dermatomyositis with facial swelling. Int J Pediatr Otorhinolaryngol 2012;76:745-9
5. Bustos BR, Carrasco AC, Toledo RC. Plasmapheresis for macrophage activation syndrome and multiorgan failure as first presentation of juvenile dermatomyositis [in Spanish]. An Pediatr (Barc) 2012;77:47-50
6. Sterba G, Rodriguez C, Sifontes S, Vigilanza P. Macrophage activation syndrome due to methotrexate in a 12-year-old boy with dermatomyositis. J Rheumatol 2004;31:1014-15
7. Ravelli A, Grom AA, Behrens EM, Cron RQ. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: Diagnosis, genetics, pathophysiology and treatment. Genes Immun 2012;13:289-98
8. Miettunen PM, Narendran A, Jayanthan A, Behrens EM, Cron RQ. Successful treatment of severe paediatric rheumatic diseaseassociated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: Case series with 12 patients. Rheumatology (Oxford) 2011;50:417-19
9. Elst EF, Kamphuis SS, Prakken BJ, Wulffraat NM, van der Net J, Peters AC, et al. Case report: Severe central nervous system involvement in juvenile dermatomyositis. J Rheumatol 2003;30:2059-63
10. Stevens CJ, Heran MK. The many faces of posterior reversible encephalopathy syndrome. Br J Radiol 2012;85:1566-75